Ottawa moves ahead with National Pharmacare deals, ensuring broader access to key medications
A national pharmacare program covering contraceptives and diabetes medications is moving forward. Prime Minister Mark Carney has confirmed the federal government’s commitment to signing deals with all provinces and territories.
This announcement ends months of uncertainty for stakeholders across the country, according to The Canadian Press.
Carney emphasized that these agreements will be finalized "as quickly and as equitably as possible," and described the government’s commitments as clear and unwavering, as reported by The Canadian Press.
The first phase of the program, launched last year, offers "universal, single-payer, first-dollar coverage" for contraceptives and certain diabetes medications, reducing out-of-pocket costs for Canadians.
So far, Manitoba, British Columbia, Prince Edward Island, and Yukon have signed agreements, representing over 60 per cent of the $1.5bn allocated in the last federal budget to launch the program, as noted by CBC News.
The pharmacare law, passed last fall, mandates that the federal government negotiate funding deals with provinces and territories and explore models for a broader universal program.
Carney acknowledged that the upcoming federal budget will involve difficult decisions to protect programs such as pharmacare, dental care, and child care.
“One of the core reasons why we're taking tough decisions is for affordability and security for Canadians,” he said, as per The Canadian Press.
He stressed the need to maintain control over federal spending to ensure continued support for these programs.
Advocacy groups have welcomed Carney’s renewed commitment.
The Canadian Health Coalition called his comments “a very positive step forward,” following protests urging the government to avoid a patchwork approach and ensure equitable access nationwide, as reported by The Canadian Press.
While the government remains focused on implementing the current phase, Carney clarified that expanding pharmacare to a full universal insurance program, as promised in the 2019 Liberal platform, “is a different question.”
The committee of experts examining models for universal pharmacare is expected to report to the health minister by October 10, with findings to be tabled in Parliament shortly thereafter.
